Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

TACROLIMUS - ANVISA Registration 80254180462

Access comprehensive regulatory information for TACROLIMUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80254180462 and manufactured by manufacturer not specified. The registration is held by PHADIA DIAGNOSTICOS LTDA with validity until Jan 02, 2034.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including SIEMENS HEALTHCARE DIAGNOSTICS INC, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80254180462
2 Related Devices
Registration Details
ANVISA Registration Number: 80254180462
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Related Devices (2)

Família QMS Tacrolimus
Risk Class III

Registration Details

80254180462

25351602714202301

04930429000139

Company Information

Dates and Status

Jan 02, 2024

02/01/2034

09/18/2025 19:00:01

Família QMS Tacrolimus
Risk Class III

Registration Details

80254180462

25351602714202301

04930429000139

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Jan 02, 2024

02/01/2034

09/18/2025 19:00:01